Literature DB >> 24770577

"Legal highs": safe and legal "heavens"? A study on the diffusion, knowledge and risk awareness of novel psychoactive drugs among students in the UK.

Ornella Corazza, Pierluigi Simonato, John Corkery, Giuseppina Trincas, Fabrizio Schifano.   

Abstract

BACKGROUND: The recent emergence of new recreational drugs, combined with the ability of the Internet to disseminate information quickly, have raised a number of concerns in the fields of drug policy, substance use research, and public health.
METHODS: A semi-structured questionnaire was advertised on The Study Room's website from November to December 2010 to explore the awareness, the use and the perception of risks of "legal highs" among student population in the UK.
RESULTS: One-third (31.40%) of the 446 participants reported use of these kinds of drugs. Respondents were more likely to have taken were: mephedrone (41.4%), Salvia divinorum (20%), "Spice drugs" (10.7%), methylone (1.4%), naphyrone (NRG) (2.1%) and benzylpiperazine (BZP) (2.1%), while 15.7% did not know what compounds they had ever consumed. The large majority (78.9%) considered these as legal substances, while 74.2% did not consider these safer than illicit drugs. Half (50.8%) of the respondents were aware of the presence of illegal agents in the products they had consumed.
CONCLUSIONS: The study contributes to an initial assessment of the use and the risks awareness of novel psychoactive compounds among students in the UK. Further research is required, especially in terms of personality and lifestyle attitudes to better profile these new forms of abuse also in non-recreational settings.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24770577     DOI: 10.1708/1461.16147

Source DB:  PubMed          Journal:  Riv Psichiatr        ISSN: 0035-6484            Impact factor:   1.911


  10 in total

1.  Impact of the UK Psychoactive Substances Act on awareness, use, experiences and knowledge of potential associated health risks of novel psychoactive substances.

Authors:  Elena Deligianni; Omari J Daniel; John M Corkery; Fabrizio Schifano; Lisa A Lione
Journal:  Br J Clin Pharmacol       Date:  2020-01-09       Impact factor: 4.335

2.  A novel psychoactive substance poses a new challenge in the management of paranoid schizophrenia.

Authors:  Caroline Anderson; Christopher Morrell; David Marchevsky
Journal:  BMJ Case Rep       Date:  2015-05-06

3.  Risk management strategies of synthetic cannabis users.

Authors:  Stephanie Campos; Ellen Benoit; Eloise Dunlap
Journal:  Drugs Alcohol Today       Date:  2019-09-02

4.  Drug abuse, relapse, and prevention education in malaysia: perspective of university students through a mixed methods approach.

Authors:  Qiu Ting Chie; Cai Lian Tam; Gregory Bonn; Chee Piau Wong; Hoang Minh Dang; Rozainee Khairuddin
Journal:  Front Psychiatry       Date:  2015-05-06       Impact factor: 4.157

5.  Awareness of users and motivational factors for using new psychoactive substances in Belgium.

Authors:  Sarah Simonis; Michaël Canfyn; Anton Van Dijck; Tina Van Havere; Eric Deconinck; Peter Blanckaert; Lies Gremeaux
Journal:  Harm Reduct J       Date:  2020-07-25

6.  Awareness survey of so-called Dappou drugs or Kiken drugs (New Psychoactive Substances) among University Students in Japan.

Authors:  Yasuko Fuse-Nagase; Fukumi Saito; Toshie Hirohara; Happei Miyakawa
Journal:  Subst Abuse Treat Prev Policy       Date:  2015-10-09

Review 7.  Adverse Psychiatric Effects Associated with Herbal Weight-Loss Products.

Authors:  F Saverio Bersani; Marialuce Coviello; Claudio Imperatori; Marta Francesconi; Christina M Hough; Giuseppe Valeriani; Gianfranco De Stefano; Flaminia Bolzan Mariotti Posocco; Rita Santacroce; Amedeo Minichino; Ornella Corazza
Journal:  Biomed Res Int       Date:  2015-09-17       Impact factor: 3.411

Review 8.  25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug.

Authors:  Francesco Saverio Bersani; Ornella Corazza; Gabriella Albano; Giuseppe Valeriani; Rita Santacroce; Flaminia Bolzan Mariotti Posocco; Eduardo Cinosi; Pierluigi Simonato; Giovanni Martinotti; Giuseppe Bersani; Fabrizio Schifano
Journal:  Biomed Res Int       Date:  2014-07-03       Impact factor: 3.411

Review 9.  Following "the Roots" of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries.

Authors:  Eduardo Cinosi; Giovanni Martinotti; Pierluigi Simonato; Darshan Singh; Zsolt Demetrovics; Andres Roman-Urrestarazu; Francesco Saverio Bersani; Balasingam Vicknasingam; Giulia Piazzon; Jih-Heng Li; Wen-Jing Yu; Máté Kapitány-Fövény; Judit Farkas; Massimo Di Giannantonio; Ornella Corazza
Journal:  Biomed Res Int       Date:  2015-11-10       Impact factor: 3.411

Review 10.  Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review From Public Health Prospective.

Authors:  Koby Cohen; Aviv M Weinstein
Journal:  Front Public Health       Date:  2018-06-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.